Author

T. Lebret

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

E. Chapeaublanc· 3 shared F. Dufour· 3 shared F. Radvanyi· 3 shared I. Bernard-Pierrot· 3 shared J. Fontugne· 3 shared Y. Allory· 3 shared A. De Reynies· 2 shared A. Kamoun· 2 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

E. Chapeaublanc

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks

H. Neyret-Kahn, J. Fontugne, X.-Y. Meng, C. S. Groeneveld, L. Cabel, T. Ye, E. Guyon, C. Krucker, F. Dufour, E. Chapeaublanc, A. Rapinat, D. C. B. Jeffery, Y. Neuzillet, T. Lebret, D. Gentien, , F. Radvanyi

The paper identifies super-enhancer networks regulating bladder cancer subtypes through transcription factors, showing their role in cell identity and inflammatory response suppression.

bioRxiv · Jan 11, 2022Cancer Biology

FGFR3 activating mutations induce luminal-like papillary bladder tumor formation and favor a male gender bias.

M. Shi, A. Moreno-Vega, J. Fontugne, X.-Y. Meng, F. Dufour, A. Kamoun, S. V. Lindskrog, A. Rapinat, C. Dunois-Larde, M.-L. Lapage, E. Chapeaublanc, O. Levrel, T. Lebret, A. Almeida, A. De Reynies, , I. BERNARD-PIERROT

This study shows FGFR3-S249C mutations drive luminal-like papillary bladder tumors in mice and correlate with male gender bias and AR activity in human tumors.

bioRxiv · Sep 2, 2021 · PreprintCancer Biology

PPARG is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities.

L. Coutos-Thevenot, S. Beji, H. Neyret-Kahn, Q. Pippo, J. Fontugne, J. Osz, C. Krucker, C. Dos Santos Groeneveld, F. Dufour, A. Kamoun, M. Ley, E. Chapeaublanc, A. De Reynies, T. Lebret, Y. Allory, , I. BERNARD-PIERROT

The paper identifies PPARγ as a tumor suppressor in basal bladder tumors and suggests therapeutic opportunities through PPARγ activation.

bioRxiv · Dec 9, 2019 · PreprintCancer Biology